Myocardial viability 87 Chronic inflammatory biomarker Myeloperoxidase (MPO)

Chronic inflammatory biomarker Myeloperoxidase (MPO) has been reported in several studies that have investigated its role in cardiopulmonary events

3Kartons25

Um das Potenzial des Wissensmanagements erschließen zu können

Since the first paper by Frechet

Vor der Erläuterung der verschiedenen Cross-Media-Strategien erfolgt im zweiten Kapitel der Arbeit [¿]

Myocardial viability 87 Chronic inflammatory biomarker Myeloperoxidase (MPO)In the past few years it has become clear that left ventricular dysfunction, even of severe degree, may be reversible after coronary revascularization in some patients. As a result, myocardial viability has captured the imagination of researchers and clinicians seeking to unravel the cellular and subcellular mechanisms and define appropriate diagnostic modalities. These diagnostic modalities include: cardiac catheterization, positron emission